Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value ...

Wellness group Ascendis Health has been making a recovery from crippling debt, but the threat of business rescue still hangs over its head. Ascendis has managed to cut it debt down from R6.7 billion ...

Investing.com -- Shares of Ascendis Pharma A/S (NASDAQ:ASND) climbed 5.8% today after the company announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review its ...

Ascendis Pharma ASND has outperformed the market over the past 10 years by 14.81% on an annualized basis producing an average annual return of 25.59%. Currently, Ascendis Pharma has a market ...

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and ...

On Tuesday, Stifel analysts reiterated their Buy rating on Ascendis Pharma (NASDAQ: ASND) shares, with a steady price target of $212.00.According to InvestingPro data, analysts maintain a Strong ...

Developed using Ascendis Pharma's proprietary TransConTM platform, SKYTROFA is delivered as a subcutaneous injection, available in various strengths.[2] The starting dose depends on the patient's ...

Ascendis Pharma A/S (ASND) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings. Skip to content Home page ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Click here to see the full list of 228 stocks from our US High Growth Tech and AI Stocks screener. Let's uncover some gems from our specialized screener. Applied Digital Simply Wall St Growth ...

Overview: Bit Digital, Inc., along with its subsidiaries, operates in the bitcoin mining industry and has a market capitalization of $502.52 million. Operations: The company is involved in bitcoin ...

C OPENHAGEN - Ascendis Pharma A/S (NASDAQ:ASND), a biopharmaceutical company valued at $7.15 billion, has initiated a share repurchase program, with plans to buy back up to $18.25 million of its ...